Literature DB >> 25038260

A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease.

Sara Boenzi1, Federica Deodato2, Roberta Taurisano2, Diego Martinelli2, Daniela Verrigni3, Rosalba Carrozzo3, Enrico Bertini3, Anna Pastore4, Carlo Dionisi-Vici2, David W Johnson5.   

Abstract

Two oxysterols, cholestan-3β,5α,6β-triol (C-triol) and 7-ketocholesterol (7-KC), have been recently proposed as diagnostic markers of Niemann-Pick type C (NP-C) disease, representing a potential alternative diagnostic tool to the more invasive and time consuming filipin test in cultured fibroblasts. Usually, the oxysterols are detected and quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) method using atmospheric pressure chemical ionization (APCI) or electro-spray-ionization (ESI) sources, after a variety of derivatization procedures to enhance sensitivity. We developed a sensitive LC-MS/MS method to quantify the oxysterols in plasma as dimethylaminobutyrate ester, suitable for ESI analysis. This method, with an easy liquid-phase extraction and a short derivatization procedure, has been validated to demonstrate specificity, linearity, recovery, lowest limit of quantification, accuracy and precision. The assay was linear over a concentration range of 0.5-200ng/mL for C-triol and 1.0-200ng/mL for 7-KC. Intra-day and inter-day coefficients of variation (CV%) were <15% for both metabolites. Receiver operating characteristic analysis estimates that the area under curve was 0.998 for C-triol, and 0.972 for 7-KC, implying a significant discriminatory power for the method in this patient population of both oxysterols. In summary, our method provides a simple, rapid and non-invasive diagnostic tool for the biochemical diagnosis of NP-C disease.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dimethylaminobutyrate ester derivative; Electrospray ionization analysis; Liquid chromatography–tandem-mass spectrometry; Niemann–Pick C disease; Oxysterols

Mesh:

Substances:

Year:  2014        PMID: 25038260     DOI: 10.1016/j.cca.2014.07.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  25 in total

1.  N-acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease.

Authors:  Rohini Sidhu; Yawo Mondjinou; Mingxing Qian; Haowei Song; Arun Babu Kumar; Xinying Hong; Fong-Fu Hsu; Dennis J Dietzen; Nicole M Yanjanin; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Michael H Gelb; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  J Lipid Res       Date:  2019-06-14       Impact factor: 5.922

Review 2.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 3.  Complex lipid trafficking in Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  J Inherit Metab Dis       Date:  2014-11-26       Impact factor: 4.982

4.  Diagnosis of niemann-pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots.

Authors:  Xuntian Jiang; Rohini Sidhu; Joseph J Orsini; Nicole Y Farhat; Forbes D Porter; Elizabeth Berry-Kravis; Jean E Schaffer; Daniel S Ory
Journal:  Mol Genet Metab       Date:  2018-08-24       Impact factor: 4.797

5.  Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1.

Authors:  Rohini Sidhu; Pamela Kell; Dennis J Dietzen; Nicole Y Farhat; An Ngoc Dang Do; Forbes D Porter; Elizabeth Berry-Kravis; Janine Reunert; Thorsten Marquardt; Roberto Giugliani; Charles M Lourenço; Raymond Y Wang; Nina Movsesyan; Ellen Plummer; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Mol Genet Metab       Date:  2020-11-18       Impact factor: 4.797

Review 6.  Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.

Authors:  Monique Piraud; Magali Pettazzoni; Pamela Lavoie; Séverine Ruet; Cécile Pagan; David Cheillan; Philippe Latour; Christine Vianey-Saban; Christiane Auray-Blais; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2018-03-19       Impact factor: 4.982

Review 7.  Diagnostic workup and management of patients with suspected Niemann-Pick type C disease.

Authors:  Apostolos Papandreou; Paul Gissen
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

8.  Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism.

Authors:  Sara Boenzi; Federica Deodato; Roberta Taurisano; Bianca Maria Goffredo; Cristiano Rizzo; Carlo Dionisi-Vici
Journal:  J Lipid Res       Date:  2016-01-05       Impact factor: 5.922

9.  Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.

Authors:  Sonia Pajares; Angela Arias; Judit García-Villoria; Judit Macías-Vidal; Emilio Ros; Javier de las Heras; Marisa Girós; Maria J Coll; Antonia Ribes
Journal:  J Lipid Res       Date:  2015-08-03       Impact factor: 5.922

10.  Mass spectrometry imaging and LC/MS reveal decreased cerebellar phosphoinositides in Niemann-Pick type C1-null mice.

Authors:  Koralege C Pathmasiri; Melissa R Pergande; Fernando Tobias; Rima Rebiai; Avia Rosenhouse-Dantsker; Ernesto R Bongarzone; Stephanie M Cologna
Journal:  J Lipid Res       Date:  2020-05-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.